Skip to content
Bored Studies
RecruitingAccepts healthy volunteersPhase 1

Study of Single Doses of HBS-104 in Acutely Sleep-deprived Healthy Participants

Harmony Biosciences Management, Inc. · NCT07848659

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18–55 · All sexes
Healthy volunteers
Accepted
Study type
Interventional · Phase 1
Target enrollment
12
US sites recruiting
1
Study start
August 28, 2026
Record last updated
September 30, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

This is a study to evaluate the pharmacodynamic effects, safety, tolerability, and pharmacokinetics of HBS-104 in acutely sleep-deprived healthy adult participants.

Being studied: HBS-104; Placebo

Conditions: Sleep Deprivation

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • Provide written informed consent before any study-related procedures are performed.
  • Be healthy as determined by assessments at the Screening Visit.

Exclusion Criteria

  • Female with a positive pregnancy test at Screening Visit or upon check-in for Period 1.
  • Is currently breastfeeding or planning to breastfeed over the course of the study. Lactating women must agree not to breastfeed for the duration of the study and for 7 days after their final dose of study drug.

Note: Additional inclusion/exclusion criteria may apply, per protocol

Recruiting US locations

Study contacts (from the official record)

  • Clinical Trials Administrator · see email · clinicaltrials@harmonybiosciences.com
All sleep studies in New Jersey →
Study of Single Doses of HBS-104 in Acutely Sleep-deprived Healthy… (NCT07848659) | Bored Studies